Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?

被引:25
|
作者
O'Donovan, James [1 ]
Watson, Rosie [1 ]
Colloby, Sean J. [1 ]
Firbank, Michael J. [1 ]
Burton, Emma J. [1 ]
Barber, Robert [1 ]
Blamire, Andrew. M. [2 ,3 ]
O'Brien, John T. [1 ]
机构
[1] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[2] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[3] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
基金
英国惠康基金;
关键词
Alzheimer's disease; dementia with Lewy bodies; MRI; TEMPORAL-LOBE ATROPHY; COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DLB; RECOMMENDATIONS; MANAGEMENT; PATHOLOGY;
D O I
10.1017/S1041610212001214
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Previous studies suggest that posterior cortical atrophy may be a useful marker for early onset Alzheimer's disease (AD). Dementia with Lewy bodies (DLB) is associated with less temporal lobe atrophy than AD, though posterior cortical atrophy may be greater. Therefore, we assessed whether visual rating scales for assessing posterior atrophy (PA), medial temporal lobe atrophy (MTA), and ventricular enlargement (VEn) aid in the discrimination between AD, DLB, and normal aging. Methods: T1-weighted MRI scans acquired at 3 Tesla were visually rated for PA (range 0-3), MTA (range 0-4), and VEn (range 0-3) in older subjects with AD (n = 36), DLB (n = 35), and healthy controls (n = 35). The diagnostic utility of MTA, PA, and VEn visual ratings in distinguishing AD and DLB from controls as well as AD from DLB was investigated. Results: Significantly higher MTA ratings were associated with AD and DLB compared to controls (p < 0.001). MTA ratings were greater in AD relative to DLB (U = 384.5, p = 0.004). For PA ratings, scores did not differ between groups (p = 0.20). VEn ratings were significantly higher in AD and DLB compared to controls (p = 0.003), but similar between AD and DLB (U = 384.5, p = 0.4). Conclusions: Unlike findings reported in younger subjects, visual ratings for PA are not a reliable marker at older ages for distinguishing AD from controls, or for distinguishing DLB from AD. However, visual ratings of MTA and VEn may be useful markers in distinguishing both AD and DLB from older subjects without dementia.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [41] 18F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy
    Nedelska, Zuzana
    Josephs, Keith A.
    Graff-Radford, Jonathan
    Przybelski, Scott A.
    Lesnick, Timothy G.
    Boeve, Bradley F.
    Drubach, Daniel A.
    Knopman, David S.
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Whitwell, Jennifer L.
    Kantarci, Kejal
    MOVEMENT DISORDERS, 2019, 34 (03) : 344 - 352
  • [42] Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRI
    Nemoto, Kiyotaka
    Sakaguchi, Hiromasa
    Kasai, Wataru
    Hotta, Masatoshi
    Kamei, Ryotaro
    Noguchi, Tomoyuki
    Minamimoto, Ryogo
    Arai, Tetsuaki
    Asada, Takashi
    JOURNAL OF NEUROIMAGING, 2021, 31 (03) : 579 - 587
  • [43] Diffusion MRI and Machine Learning Distinguish Alzheimer's Disease and Dementia with Lewy Bodies
    Chen, R.
    Wang, W.
    Barmpoutis, A.
    Vaillancourt, D.
    MOVEMENT DISORDERS, 2024, 39 : S436 - S436
  • [44] Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies
    Mak, Elijah
    Su, Li
    Williams, Guy B.
    Watson, Rosie
    Firbank, Michael
    Blamire, Andrew M.
    OBrien, John T.
    NEUROIMAGE-CLINICAL, 2015, 7 : 456 - 462
  • [45] Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease
    Delli Pizzi, Stefano
    Franciotti, Raffaella
    Bubbico, Giovanna
    Thomas, Astrid
    Onofrj, Marco
    Bonanni, Laura
    NEUROBIOLOGY OF AGING, 2016, 40 : 103 - 109
  • [46] Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology
    van der Zande, Jessica J.
    Steenwijk, Martijn D.
    ten Kate, Mara
    Wattjes, Mike P.
    Scheltens, Philip
    Lemstra, Afina W.
    NEUROBIOLOGY OF AGING, 2018, 71 : 171 - 178
  • [47] CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer′s disease
    del Campo, Marta
    Vermunt, Lisa
    Peeters, Carel F. W.
    Sieben, Anne
    Hok-A-Hin, Yanaika S.
    Lleo, Alberto
    Alcolea, Daniel
    van Nee, Mirrelijn
    Engelborghs, Sebastiaan
    van Alphen, Juliette L.
    Arezoumandan, Sanaz
    Chen-Plotkin, Alice
    Irwin, David J.
    van der Flier, Wiesje M.
    Lemstra, Afina W.
    Teunissen, Charlotte E.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [48] Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease
    Hanyu, H.
    Sato, T.
    Hirao, K.
    Kanetaka, H.
    Sakurai, H.
    Iwamoto, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (02) : 212 - 217
  • [49] Comparison of caregiver burden between dementia with Lewy bodies and Alzheimer's disease
    Yuuki, Seiji
    Hashimoto, Mamoru
    Koyama, Asuka
    Matsushita, Masateru
    Ishikawa, Tomohisa
    Fukuhara, Ryuji
    Honda, Kazuki
    Miyagawa, Yusuke
    Ikeda, Manabu
    Takebayashi, Minoru
    PSYCHOGERIATRICS, 2023, 23 (04) : 682 - 689
  • [50] CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
    Marta del Campo
    Lisa Vermunt
    Carel F. W. Peeters
    Anne Sieben
    Yanaika S. Hok-A-Hin
    Alberto Lleó
    Daniel Alcolea
    Mirrelijn van Nee
    Sebastiaan Engelborghs
    Juliette L. van Alphen
    Sanaz Arezoumandan
    Alice Chen-Plotkin
    David J. Irwin
    Wiesje M. van der Flier
    Afina W. Lemstra
    Charlotte E. Teunissen
    Nature Communications, 14